{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:47:12Z","timestamp":1782902832295,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100022502","name":"Mereo BioPharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12325-025-03372-8","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T14:10:10Z","timestamp":1758895810000},"page":"5811-5829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The IMPACT Survey: The Humanistic Impact of Caring for an Individual with Osteogenesis Imperfecta"],"prefix":"10.1007","volume":"42","author":[{"given":"Ingunn","family":"Westerheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Lande","family":"Wekre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco","family":"van Welzenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Raggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Mulhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysia","family":"Battersby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"3372_CR1","doi-asserted-by":"crossref","unstructured":"Prince S, van Welzenis T, Wekre LL, et al. Comparing the humanistic and economic impact of osteogenesis imperfecta affected and non-affected caregivers, who care for an individual with osteogenesis imperfecta. Value Health. 2024;27(12):S542\u2013S543.","DOI":"10.1016\/j.jval.2024.10.3427"},{"key":"3372_CR2","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14322","volume":"146","author":"A Bregou Bourgeois","year":"2016","unstructured":"Bregou Bourgeois A, Aubry-Rozier B, Bonaf\u00e9 L, Laurent-Applegate L, Pioletti DP, Zambelli PY. Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives. Swiss Med Wkly. 2016;146:w14322.","journal-title":"Swiss Med Wkly"},{"key":"3372_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"key":"3372_CR4","unstructured":"Folkestad L. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark. Dani Med J. 2018;65(4):B5454."},{"key":"3372_CR5","unstructured":"Bishop NJ. Osteogenesis imperfecta. Orphanet 2021. https:\/\/www.orpha.net\/en\/disease\/detail\/666. Accessed 11 Dec 2024."},{"issue":"2","key":"3372_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101\u201316.","journal-title":"J Med Genet"},{"issue":"1","key":"3372_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/jbmr.2920","volume":"32","author":"L Folkestad","year":"2017","unstructured":"Folkestad L, Hald JD, Ersb\u00f8ll AK, et al. Fracture rates and fracture sites in patients with osteogenesis imperfecta: a nationwide register-based cohort study. J Bone Miner Res. 2017;32(1):125\u201334.","journal-title":"J Bone Miner Res"},{"key":"3372_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101493","author":"M Botor","year":"2021","unstructured":"Botor M, Fus-Kujawa A, Uroczynska M, et al. Osteogenesis imperfecta: current and prospective therapies. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11101493.","journal-title":"Biomolecules"},{"issue":"8","key":"3372_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10174","volume":"3","author":"JT Tauer","year":"2019","unstructured":"Tauer JT, Robinson ME, Rauch F. Osteogenesis imperfecta: new perspectives from clinical and translational research. JBMR Plus. 2019;3(8):e10174.","journal-title":"JBMR Plus"},{"issue":"10","key":"3372_CR10","volume":"10","author":"K Dwan","year":"2016","unstructured":"Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2016;10(10):CD005088.","journal-title":"Cochrane Database Syst Rev"},{"key":"3372_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/JMDH.S113483","volume":"10","author":"C Marr","year":"2017","unstructured":"Marr C, Seasman A, Bishop N. Managing the patient with osteogenesis imperfecta: a multidisciplinary approach. J Multidiscip Healthc. 2017;10:145\u201355.","journal-title":"J Multidiscip Healthc"},{"issue":"4","key":"3372_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4055\/cios20060","volume":"12","author":"TJ Cho","year":"2020","unstructured":"Cho TJ, Ko JM, Kim H, Shin HI, Yoo WJ, Shin CH. Management of osteogenesis imperfecta: a multidisciplinary comprehensive approach. Clin Orthop Surg. 2020;12(4):417\u201329.","journal-title":"Clin Orthop Surg"},{"issue":"2","key":"3372_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1172\/JCI71101","volume":"124","author":"ES Orwoll","year":"2014","unstructured":"Orwoll ES, Shapiro J, Veith S, et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta. J Clin Invest. 2014;124(2):491\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"3372_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-023-02627-3","volume":"18","author":"M Rapoport","year":"2023","unstructured":"Rapoport M, Bober MB, Raggio C, et al. The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review. Orphanet J Rare Dis. 2023;18(1):34.","journal-title":"Orphanet J Rare Dis"},{"key":"3372_CR15","doi-asserted-by":"publisher","unstructured":"Wiggins S, Kreikemeier R. Bisphosphonate therapy and osteogenesis imperfecta: the lived experience of children and their mothers. J Spec Pediatric Nurs: JSPN. 2017;22(4). https:\/\/doi.org\/10.1111\/jspn.12192.","DOI":"10.1111\/jspn.12192"},{"issue":"3","key":"3372_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.dhjo.2018.12.003","volume":"12","author":"M Hill","year":"2019","unstructured":"Hill M, Lewis C, Riddington M, et al. Exploring the impact of osteogenesis imperfecta on families: a mixed-methods systematic review. Disabil Health J. 2019;12(3):340\u20139.","journal-title":"Disabil Health J"},{"issue":"7","key":"3372_CR17","first-page":"764","volume":"65","author":"LB Arabaci","year":"2015","unstructured":"Arabaci LB, Bozkurt S, Vara S, Ozen S, Darcan S, Simsek DG. Difficulties experienced by caregivers of patients diagnosed with osteogenesisimperfecta (OI): example of a hospital. J Pak Med Assoc. 2015;65(7):764\u201370.","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"3372_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4274\/jcrpe.1304","volume":"6","author":"S Bozkurt","year":"2014","unstructured":"Bozkurt S, Vara S, Ozen S, G\u00f6k\u015fen D, Darcan S. The impact of psycho-educational training on the psychosocial adjustment of caregivers of osteogenesis imperfecta patients. J Clin Res Pediatr Endocrinol. 2014;6(2):84\u201392.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"19","key":"3372_CR19","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1080\/09638288.2017.1334236","volume":"40","author":"MCD Santos","year":"2018","unstructured":"Santos MCD, Pires AF, Soares K, Barros L. Family experience with osteogenesis imperfecta type\u00a01: the most distressing situations. Disabil Rehabil. 2018;40(19):2281\u20137.","journal-title":"Disabil Rehabil"},{"issue":"3","key":"3372_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.dhjo.2014.03.002","volume":"7","author":"MJ Dogba","year":"2014","unstructured":"Dogba MJ, Rauch F, Tre G, Glorieux FH, Bedos C. Shaping and managing the course of a child\u2019s disease: parental experiences with osteogenesis imperfecta. Disabil Health J. 2014;7(3):343\u20139.","journal-title":"Disabil Health J"},{"issue":"1","key":"3372_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2431-13-153","volume":"13","author":"MJ Dogba","year":"2013","unstructured":"Dogba MJ, Bedos C, Durigova M, et al. The impact of severe osteogenesis imperfecta on the lives of young patients and their parents\u2014a qualitative analysis. BMC Pediatr. 2013;13(1):153.","journal-title":"BMC Pediatr"},{"key":"3372_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12955-015-0226-4","volume":"13","author":"AP Vanz","year":"2015","unstructured":"Vanz AP, F\u00e9lix TM, da Rocha NS, Schwartz IV. Quality of life in caregivers of children and adolescents with osteogenesis imperfecta. Health Qual Life Outcomes. 2015;13:41.","journal-title":"Health Qual Life Outcomes"},{"key":"3372_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12101018","author":"A Aratti","year":"2024","unstructured":"Aratti A, Zampini L. Caregiver burden, parenting stress and coping strategies: the experience of parents of children and adolescents with osteogenesis imperfecta. Healthcare. 2024. https:\/\/doi.org\/10.3390\/healthcare12101018.","journal-title":"Healthcare"},{"key":"3372_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-12-54","volume":"12","author":"CL Hill","year":"2014","unstructured":"Hill CL, Baird WO, Walters SJ. Quality of life in children and adolescents with osteogenesis imperfecta: a qualitative interview based study. Health Qual Life Outcomes. 2014;12:54.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"3372_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13023-024-03218-6","volume":"19","author":"T Hart","year":"2024","unstructured":"Hart T, Westerheim I, van Welzenis T, et al. The IMPACT survey: the economic impact of osteogenesis imperfecta in adults. Orphanet J Rare Dis. 2024;19(1):222.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3372_CR26","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1186\/s12889-024-20555-0","volume":"24","author":"T van Welzenis","year":"2024","unstructured":"van Welzenis T, Westerheim I, Hart T, et al. The IMPACT survey: the humanistic impact of osteogenesis imperfecta in adults. BMC Public Health. 2024;24(1):3318.","journal-title":"BMC Public Health"},{"issue":"1","key":"3372_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13023-024-03126-9","volume":"19","author":"I Westerheim","year":"2024","unstructured":"Westerheim I, Hart T, van Welzenis T, et al. The IMPACT survey: a mixed methods study to understand the experience of children, adolescents and adults with osteogenesis imperfecta and their caregivers. Orphanet J Rare Dis. 2024;19(1):128.","journal-title":"Orphanet J Rare Dis"},{"key":"3372_CR28","unstructured":"IMPACT. The IMPACT Survey. https:\/\/impact-hub-website.squarespace.com\/. Accessed 11 Dec 2024."},{"key":"3372_CR29","unstructured":"UK Research Integrity Office. Good practice in research: Internet-mediated research 2016. https:\/\/ukrio.org\/wp-content\/uploads\/UKRIO-Guidance-Note-Internet-Mediated-Research-v1.0.pdf. Accessed 11 Dec 2024."},{"key":"3372_CR30","unstructured":"Association EPMR. Code of Conduct. 2024."},{"key":"3372_CR31","unstructured":"Commerce ICo. ICC\/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics. 2025."},{"key":"3372_CR32","unstructured":"REGULATION (EU) 2016\/679 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation), 2016\/679 (2016)."},{"issue":"Suppl(Suppl)","key":"3372_CR33","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1177\/0022146510383501","volume":"51","author":"D Umberson","year":"2010","unstructured":"Umberson D, Montez JK. Social relationships and health: a flashpoint for health policy. J Health Soc Behav. 2010;51(Suppl(Suppl)):S54\u201366.","journal-title":"J Health Soc Behav"},{"issue":"1","key":"3372_CR34","first-page":"99","volume":"21","author":"A Szczepaniak-Kubat","year":"2012","unstructured":"Szczepaniak-Kubat A, Kurnatowska O, Jakubowska-Pietkiewicz E, Chlebna-Sok\u00f3\u0142 D. Assessment of quality of life of parents of children with osteogenesis imperfecta. Adv Clin Exp Med. 2012;21(1):99\u2013104.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"3372_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147654","volume":"11","author":"MJ Dogba","year":"2016","unstructured":"Dogba MJ, Dahan-Oliel N, Snider L, et al. Involving families with osteogenesis imperfecta in health service research: joint development of the OI\/ECE questionnaire. PLoS One. 2016;11(1):e0147654.","journal-title":"PLoS One"},{"issue":"2","key":"3372_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10545-010-9267-3","volume":"34","author":"AE ten Hoedt","year":"2011","unstructured":"ten Hoedt AE, Maurice-Stam H, Boelen CC, et al. Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life. J Inherit Metab Dis. 2011;34(2):391\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"3372_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10782","volume":"7","author":"KK Joshi","year":"2023","unstructured":"Joshi KK, Siafarikas A, Prince R. The natural history of symptomatic fractures in children and adolescents with osteogenesis imperfecta type\u00a01: a cohort study from Western Australia. JBMR Plus. 2023;7(9):e10782.","journal-title":"JBMR Plus"},{"issue":"5","key":"3372_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/S2045796018000409","volume":"28","author":"M Dey","year":"2019","unstructured":"Dey M, Paz Castro R, Haug S, Schaub MP. Quality of life of parents of mentally-ill children: a systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019;28(5):563\u201377.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"2","key":"3372_CR39","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1542\/peds.111.2.e153","volume":"111","author":"SJ Suskauer","year":"2003","unstructured":"Suskauer SJ, Cintas HL, Marini JC, Gerber LH. Temperament and physical performance in children with osteogenesis imperfecta. Pediatrics. 2003;111(2):e153\u201361.","journal-title":"Pediatrics"},{"key":"3372_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18157985","author":"M Sell","year":"2021","unstructured":"Sell M, Daubmann A, Zapf H, et al. Family functioning in families affected by parental mental illness: parent, child, and clinician ratings. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18157985.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"3372_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/2156869320912520","volume":"11","author":"C Kamis","year":"2021","unstructured":"Kamis C. The long-term impact of parental mental health on children\u2019s distress trajectories in adulthood. Soc Ment Health. 2021;11(1):54\u201368.","journal-title":"Soc Ment Health"},{"issue":"1","key":"3372_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15295192.2022.2036940","volume":"23","author":"HE Yaremych","year":"2023","unstructured":"Yaremych HE, Persky S. Recruiting fathers for parenting research: an evaluation of eight recruitment methods and an exploration of fathers\u2019 motivations for participation. Parenting. 2023;23(1):1\u201332.","journal-title":"Parenting"},{"key":"3372_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/children9050627","author":"SY Chu","year":"2022","unstructured":"Chu SY, Wen CC, Weng CY. Gender differences in caring for children with genetic or rare diseases: a mixed-methods study. Children (Basel). 2022. https:\/\/doi.org\/10.3390\/children9050627.","journal-title":"Children (Basel)"},{"issue":"8","key":"3372_CR44","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s11136-016-1247-0","volume":"25","author":"A Tsimicalis","year":"2016","unstructured":"Tsimicalis A, Denis-Larocque G, Michalovic A, et al. The psychosocial experience of individuals living with osteogenesis imperfecta: a mixed-methods systematic review. Qual Life Res. 2016;25(8):1877\u201396.","journal-title":"Qual Life Res"},{"issue":"1","key":"3372_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13023-022-02561-w","volume":"17","author":"K Sandilands","year":"2022","unstructured":"Sandilands K, Williams A, Rylands AJ. Carer burden in rare inherited diseases: a literature review and conceptual model. Orphanet J Rare Dis. 2022;17(1):428.","journal-title":"Orphanet J Rare Dis"},{"key":"3372_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pedn.2023.08.026","volume":"73","author":"MD Dlamini","year":"2023","unstructured":"Dlamini MD, Chang Y-J, Nguyen TTB. Caregivers\u2019 experiences of having a child with cerebral palsy. A meta-synthesis. J Pediatric Nurs. 2023;73:157\u201368.","journal-title":"J Pediatric Nurs"},{"issue":"1","key":"3372_CR47","first-page":"24","volume":"12","author":"JR Shapiro","year":"2012","unstructured":"Shapiro JR, Germain-Lee EL. Osteogenesis imperfecta: effecting the transition from adolescent to adult medical care. J Musculoskelet Neuronal Interact. 2012;12(1):24\u20137.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"1","key":"3372_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pec.2016.08.011","volume":"100","author":"G Heath","year":"2017","unstructured":"Heath G, Farre A, Shaw K. Parenting a child with chronic illness as they transition into adulthood: a systematic review and thematic synthesis of parents\u2019 experiences. Patient Educ Couns. 2017;100(1):76\u201392.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"3372_CR49","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s11136-020-02724-x","volume":"30","author":"LN Ferreira","year":"2021","unstructured":"Ferreira LN, Pereira LN, da F\u00e9 Br\u00e1s M, Ilchuk K. Quality of life under the COVID-19 quarantine. Qual Life Res. 2021;30(5):1389\u2013405.","journal-title":"Qual Life Res"},{"issue":"S2","key":"3372_CR50","volume":"93","author":"F Dellafiore","year":"2022","unstructured":"Dellafiore F, Arrigoni C, Nania T, et al. The impact of COVID-19 pandemic on family caregivers\u2019 mental health: a rapid systematic review of the current evidence. Acta Biomed. 2022;93(S2):e2022154.","journal-title":"Acta Biomed"},{"issue":"1","key":"3372_CR51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12913-024-11191-w","volume":"24","author":"D Pacheco Barzallo","year":"2024","unstructured":"Pacheco Barzallo D, Schnyder A, Zanini C, Gemperli A. Gender differences in family caregiving. Do female caregivers do more or undertake different tasks? BMC Health Serv Res. 2024;24(1):730.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"3372_CR52","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ejhg.2015.81","volume":"23","author":"K Lindahl","year":"2015","unstructured":"Lindahl K, \u00c5str\u00f6m E, Rubin C-J, et al. Genetic epidemiology, prevalence, and genotype\u2013phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet. 2015;23(8):1042\u201350.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"3372_CR53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jval.2020.01.015","volume":"23","author":"C McLoughlin","year":"2020","unstructured":"McLoughlin C, Goranitis I, Al-Janabi H. Validity and responsiveness of preference-based quality-of-life measures in informal carers: a comparison of 5 measures across 4 conditions. Value Health. 2020;23(6):782\u201390.","journal-title":"Value Health"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03372-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:45:19Z","timestamp":1761986719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03372-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03372-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Heather Mulhall and Alysia Battersby are employees of Wickenstones Ltd, Oxford, UK. Samantha Prince is an employee of Mereo BioPharma Group London, UK. At the time of the survey design and development of this report, Samantha Prince was an employee of Wickenstones Ltd. Ingunn Westerheim, Tracy Hart, Taco van Welzenis, Lena Lande Wekre, Oliver Semler, Cathleen Raggio, and Frank Rauch have provided expert consulting to Mereo BioPharma Group London, UK. Tracy Hart serves as the Chief Executive Officer of the Osteogenesis Imperfecta Foundation who have received unrestricted educational grants from Mereo BioPharma Group London, UK and Ultragenyx Pharmaceuticals Inc, Novato, USA. Oliver Semler has participated in a national advisory board for Mereo BioPharma Group London, UK and has received study contracts for clinical studies from Ultragenyx Pharmaceuticals Inc, Novato, USA. Frank Rauch has received study contracts for experimental preclinical studies with Precithera Inc, Quebec, Canada, Mesentech Inc, Vancouver, Canada and Catabasis Pharmaceuticals Inc, Cambridge, USA. He has participated in advisory boards for Ultragenyx Pharmaceuticals Inc, Novato, USA, Sanofi S.A. Paris, France, Novartis International AG, Basel, Switzerland and Mereo BioPharma Group, London, UK. Frank Rauch has received a speaker fee from Ultragenyx Pharmaceuticals Inc, Novato, USA for a lecture and received a donation of experimental drugs for a preclinical study from Acceleron Pharma Inc, Cambridge, USA. Cathleen Raggio received an institutional grant from and has been a speaker for BioMarin Pharmaceuticals Inc, Novato, California, has participated in advisory boards for Ultragenyx Pharmaceuticals Inc, Novato, USA. She has received an institutional grant from and is a consultant for Nextcure, Beltville, MD, USA. Cathleen Raggio sits on the board of directors of the Osteogenesis Imperfecta Foundation. Cathleen Raggio has also participated in an advisory board for Mereo BioPharma Group, London, UK. Taco van Welzenis and Ingunn Westerheim hold leadership positions in the Osteogenesis Imperfecta Federation Europe, which has received grants from Mereo BioPharma Group, London, UK (unrestricted), Ultragenyx Pharmaceuticals Inc, Novato, USA (restricted grant for a conference), Quince Therapeutics Inc, San Francisco, CA, USA (donation for a conference), UCB (restricted grant to conference), Angitia Biopharmaceuticals Inc., Woodland Hills, CA, USA (donation to conference), Azafaros BV, Naarden, the Netherlands (donation to conference), Alexion Inc. Boston, MA, USA, (sponsorship of conference); Pega Medical Inc, Laval, Quebec, Canada (donation), PuREC, Shimane, Japan (sponsorship of conference) and Takeda, Tokyo, Japan (payment to Ingunn Westerheim as a panellist; donated to OIFE).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The need for informed consent was waived, and an ethics approval exemption was granted for this study by Pearl IRB Indianapolis, IN, USA, (registered with OHRP and FDA; organisation number 0006471, registration number 00007772) according to FDA 21 CFR 56.104 and 45CFR46.104(b)(2): (2) Tests, Surveys, Interviews on 23 June 2021. The survey protocol is in line with the UK Research Integrity Office\u2019s guidance on good practice in internet-mediated research [\n                      \n                      ]. This online survey was anonymous and did not collect identifiable data on individuals. Participants were provided with a data privacy statement and consented for their responses to be analysed. Further, the study aligned with key principles of the EphMRA Code of Practice, including informing respondents in the survey landing page with a clear understanding of the purpose of the data collection, how it will be used (i.e. analysis and publication), anonymity, non-promotion, the right to withdraw, participation is voluntary, and data protection principles [\n                      \n                      ]. Additionally, the study aligns with the key principles of ESOMAR, including transparent information on what data will be collected, how it will be used and who it may be shared with; and ensuring data protection and ethical behaviour by researchers [\n                      \n                      ]. Participants were informed of the use of the data (as described above) prior to initiating the survey and indicated their consent by continuing to enter and complete the survey. Because the survey collected sensitive information about participants, all data were anonymised from data collection onwards. Participants did not provide names, email addresses or other identifiers, and internet protocol (IP) addresses were never captured within the survey platform. Provided data were handled in line with General Data Protection Regulation (GDPR) guidance [\n                      \n                      ].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}